Skip to main content
PLOS One logoLink to PLOS One
. 2020 Dec 31;15(12):e0244730. doi: 10.1371/journal.pone.0244730

The 10-year course of mental health, quality of life, and exile life functioning in traumatized refugees from treatment start

Marianne Opaas 1,*, Tore Wentzel-Larsen 1,2, Sverre Varvin 3
Editor: James Curtis West4
PMCID: PMC7775068  PMID: 33382807

Abstract

Refugee patients with severe traumatic experiences may need mental health treatment, but treatment results vary, and there is scarcity of studies demonstrating refugees’ long-term health and well-being after treatment. In a 10-year naturalistic and longitudinal study, 54 multi-origin traumatized adult refugee patients, with a background of war and persecution, and with a mean stay in Norway of 10.5 years, were recruited as they entered psychological treatment in mental health specialist services. The participants were interviewed face-to-face with multiple methods at admittance, and at varying points in time during and after psychotherapy. The aim was to study the participants’ trajectories of symptoms of post-traumatic stress, anxiety and depression, four aspects of quality of life, and two aspects of exile life functioning. Linear mixed effects analyses included all symptoms and quality of life measures obtained at different times and intervals for the participants. Changes in exile life functioning was investigated by exact McNemar tests. Participants responded to the quantitative assessments up to eight times. Length of therapy varied, with a mean of 61.3 sessions (SD = 74.5). The participants improved significantly in symptoms, quality of life, and exile life functioning. Improvement in symptoms of posttraumatic stress, anxiety, and depression yielded small effect sizes (r = .05 to .13), while improvement in quality of psychological and physical health yielded medium effect sizes (r = .38 and .32). Thus, long-time improvement after psychological therapy in these severely traumatized and mostly chronified refugee patients, was more notable in quality of life and exile life functioning than in symptom reduction. The results imply that major symptom reduction may not be attainable, and may not be the most important indication of long-term improvement among refugees with long-standing trauma-related suffering. Other indications of beneficial effects should be applied as well.

Introduction

Research among refugees hosted in Europe, North-America, and Australia has shown an overrepresentation of mental health suffering among individuals with a refugee background compared to the majority populations [13], even after many years in the host country [4]. This implies a challenge to the mental health system. In this paper, we examine the long-term trajectories of mental health, quality of life, and two aspects of functioning in exile of resettled refugees who sought treatment for trauma-related disorders in Norwegian mental health settings more than 10 years ago. At that time, there were only about 125 000 individuals with a refugee background in Norway, and the largest groups originated from Iraq, Somalia, Bosnia-Hercegovina, and Iran. Now the number is almost twice as high [5].

Refugees flee from conflict, persecution, violence, imprisonment, torture, and other human rights violations—sometimes from experiences beyond our imagination. Moreover, they often cope with severe dangers and obstacles, and mobilize substantial resources, strength, and adaptability on their way to refuge [6, 7]. Some are able to maintain their psychological equilibrium after adverse and dramatic experiences and may show considerable resilience [8, 9]. However, the multiple losses inherent in having to leave all that is known behind, adverse experiences during flight, and the challenges and hardships in exile add to the burden refugees need to cope with [10]. Together, this seriously challenges afflicted refugees’ capacity for resilience. A sizeable proportion develop symptoms of posttraumatic stress, depression and other mental health disorders, and may be in need of mental health treatment, but still, most traumatized refugees go untreated [11].

In addition to war-related trauma preceding flight, many refugees have suffered adverse and potentially traumatic experiences during childhood and adolescence [12, 13]. Many refugees have thus been exposed to what is referred to as complex trauma [14], which includes exposure to multiple, cumulative, and prolonged human-caused potentially traumatic experiences such as childhood abuse, domestic violence, sexual and physical assault, persecution, torture, combat, and other life threatening experiences. Exposure to complex trauma may lead to a decreased threshold for PTSD, and problems of personality functioning, such as affect dysregulation, relational difficulties, identity disturbance, and problematic behaviour [15]. The ACE (Adverse Childhood Experiences) study has convincingly demonstrated that childhood adversities above a certain level predict psychological and physical health problems, reduced prosperity, and premature death [16].

Research has shown that a higher exposure to traumatic experiences before and after migration is associated with PTSD, depression and anxiety [1]. Up to one third of the refugee population may have posttraumatic stress disorder (PTSD), often comorbid with other anxiety-related disorders and depression [17]. Physical health disorders [18, 19] and physical pain [20] are also frequent among refugees. Berthold et al. [21] found that the number of physical health problems was doubled in refugees with PTSD and depression, compared to refugees without these mental health disorders. Furthermore, chronic pain was found to be frequent among multi-traumatized refugees in outpatient mental health clinics in Norway, and the level of pain was positively related to their symptomatology and severity of psychiatric morbidity [22]. The extent of mental and physical symptoms and problems of living in exile have severe consequences for the refugees’ wellbeing and capacity to function [23, 24].

Studies including measures of quality of life (QOL) have shown that refugees’ QOL is lower [25], and in clinical samples way below international population norms [12, 26]. Furthermore, a significant negative relationship between PTSD symptoms and subjective QOL has been demonstrated [27, 28]. The more severe the refugees’ mental health symptoms, the poorer their quality of life [25]. Refugees’ frequent psychosocial problems and exposure to post-migration stressors, such as unemployment, poverty, unstable housing, discrimination, social marginalisation, exclusion, and weak social network, impact negatively on their mental health, adaptation and well-being [6], and may diminish their ability to recover from pre-migration trauma [29]. Among multi-traumatized refugee patients, Teodorescu et al. [30] found that unemployment, weak social network and weak social integration into the Norwegian community were significantly associated with more psychiatric morbidity and poorer quality of life.

Several studies have shown the interdependence between mastering the language of the host country, completing education or holding employment and mental health, well being, and functioning well in exile [3133]. After resettlement, refugees are expected to attend programs to learn the exile language and then get financially independent, but refugees with mental health problems may have difficulties fulfilling these expectations. In a Swiss study, difficulties with communication and employment, together with isolation, were found to be among the most serious difficulties for traumatized refugee patients [31]. The authors proposed a circular association between mental disorders connected with posttraumatic and postmigratory stress, functional impairment, and postmigration living difficulties.

Reviews, meta-studies, and systematic reviews of mental health treatment outcome among refugees with trauma-related disorders, have shown positive mean effects on mental health symptoms [3439], although within studies variation in individual participants’ improvement is commonly great [40, 41]. What most reviews have in common is a compilation of studies with relative short follow-up after termination of the intervention (usually up to a few months) and with outcome measures restricted to mental health symptoms (and sometimes somatic symptoms). A few single clinical studies with longer follow-up, report improved outcome with time. A 10-year follow-up [42] of traumatized refugee patients evidenced a 30% decrease in participants qualifying for a PTSD diagnosis. The study demonstrated that improvement in this patient group may take time, and continue over time, but at the same time, it is noteworthy that 56% retained their diagnosis of PTSD and 69% their diagnosis of depression, evidencing significant chronicity. Correspondingly, Buhmann et al. [43] found no significant effect immediately following intervention, but the six and 18 months follow-ups of their study [44] demonstrated a small improvement over time in PTSD, depression and anxiety symptoms, and in level of functioning. However, the majority of the participants still had symptom scores above clinical cut-off. These studies indicate that many or most refugee patients retain their diagnosis/-es after treatment and only some improve clinically significantly–that is–to an amount that makes a difference to their lives. Therefore, longer follow-up is necessary to study improvement after therapy in this patient group.

The comorbidity of refugees’ mental health problems and physical ailments, the daily life struggles in exile, and the complex needs of refugees and asylum seekers are acknowledged among refugee researchers [17, 38]. To reach clinically significant improvement, patients with complex disorders and difficult psychosocial living conditions need longer duration of therapy than what is ordinarily offered [45], and many may not improve to the level that is expected in other patient groups [46]. There is, however, no simple relationship between mental health improvement and therapeutic dose (e.g., number of sessions). Thus, studies on refugee patients investigating the effect of therapeutic dose on outcome showed only weak and inconsistent findings [47, 48]. Psychotherapy research in general [46] has demonstrated that after the first few sessions, other factors within and outside therapy begin to merge with sheer exposure to therapy in terms of number of sessions.

According to researchers in the refugee field, treatment approaches need special tailoring and additional approaches to be of benefit to the complex trauma and life situations of refugees [17, 29, 43]. The potential helpfulness of psychotherapy for traumatized refugees rests, at a basic level, then, on having enough therapy resources to be able to offer the necessary amount of sessions, having a reservoir of interventions that can be adjusted to individual needs, and on the therapist’s skills in engaging the patient so that he or she remains in therapy until positive change is accomplished.

The short- and long-term effects of psychological treatment for refugees and what constitutes positive outcomes are only starting to be investigated [49]. Of note is also that patients’ evaluations of “good outcome” or “no change” may not coincide with therapists’ evaluations or with symptoms changes [50]. Researchers in the field of refugee mental health have underlined the need to do more research into refugees’ optimal health outcomes, the mechanisms of improvement and chronicity, the durability of treatment effects, and to not only focus on PTSD, but to study a wider scope of therapy outcome, including improvement in other aspects of mental health, functioning, relational security, and quality of psychological, physical, and social well-being [35, 51, 52]. More knowledge is thus needed about whether and how psychological therapies can be helpful, about outcomes in addition to symptoms improvement, such as psychological and physical wellbeing, relational and exile life functioning, and about the effect of treatment over time. The present study is an attempt to fill this knowledge gap. The aim was to examine the long-term changes in mental health, quality of life, and in two aspects of exile life functioning (exile language competence and employment/study status) among refugee patients in a naturalistic follow-up study from treatment start in mental health treatment units, through treatment, and for some time after termination.

Method

In this study, individuals with backgrounds as asylum seekers or refugees will briefly be termed refugees. Moreover, the term ‘traumatized’ generically refers to having experienced severe, repeated, diverse, and potentially traumatizing events, preceding the development of mental health disorder.

Design

In a longitudinal and naturalistic study from 2006 to 2017, 54 traumatized refugee patients responded to repeated interviews comprising qualitative and quantitative research methods assessing the course of their mental health, quality of life, and exile life functioning. Their therapists were also interviewed one or more times. The study was designed to obtain a comprehensive understanding of refugee patients’ mental health and wellbeing over time, in context of their past and present life circumstances, their traumatic experiences, and their therapy experience. The treatment consisted of psychological therapy/psychotherapy and was conducted under naturalistic conditions in publicly funded, outpatient mental health services in the Oslo area, Norway. There are no specialized treatment units for traumatized refugees in Norway; treatment is provided within the general mental health services.

Participants were consecutively recruited into the study during the years 2006 to 2009. Inclusion criteria were: patients with severe mental health problems, age 18 to 65, with a history as refugee/asylum seeker with potentially traumatic experiences related to war, persecution, torture and other severe human rights violations, newly accepted for mental health treatment. A PTSD diagnosis was not required as the study sought to include various mental health problems that might ensue among refugees in the aftermath of potentially traumatic events. An ability to communicate in Norwegian was not required. Exclusion criteria were presence of psychosis or drug abuse, if severe enough to hinder research assessment.

The study was approved by the Norwegian South-East Regional Committee for Medical and Health Research Ethics [53] and therapy was conducted according to the Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [54]. Participants’ written, informed consent was required to take part in the study. The first consent was limited to three years. After three years, the participants were asked if they wanted to continue taking part in the study, and those who accepted, gave a new, non-time-limited informed and written consent.

Results from intake assessment [12, 55] and from 1- and 3-year follow-up [56] have previously been published. The pre-treatment analyses demonstrated that the participants had suffered extensive potentially traumatic events related to war and persecution [55] as well as adverse and potentially traumatic events during childhood [12]. The three-year follow-up study [56], including symptoms of posttraumatic stress disorder (PTSD), anxiety, and depression, and four aspects of quality of life (QOL) revealed significant group-level improvement in Depression, Anxiety, PTSD Arousal symptoms, and in the QOL domains Physical Health, Psychological Health, and Social Relationships. Length of treatment varied, and at the three-year follow-up, 29% of the therapies were still not terminated. For further details and a discussion of the findings, see [56, 57].

By 2017, all therapies were terminated, and most of them had been terminated for five or more years. The current study encompasses all quantitative follow-up data from the ten-year data collection period.

Participants

The participants, 35 men and 19 women, came from 15 different countries in Asia, Europe, and Africa. Of these, 57.4% (n = 31) came from countries in the Middle East, 16.7% (n = 9) came from other Asian countries, 16.7% (n = 9) came from countries in the Balkans, and 9.3% (n = 5) came from various African countries. According to their responses to the Harvard Trauma Questionnaire checklist (HTQ, Part 1) [65] on traumatic events, the participants had experienced a mean of more than 16 different kinds of potentially traumatic events related to war, persecution and human rights violations, mostly in early adulthood, including exposure to torture in 52.8%, and rape in 20.8% of the participants. In addition, 92% of the participants had suffered various adverse and potentially traumatic experiences during their childhood, such as loss of parents, severe illness or accidents, domestic violence, and witnessing violence and killings outside the home [12]. At the time of intake to the study, mean age was 39.3 (SD = 8.2), mean stay in Norway was 10.5 years (SD = 6.5), 50.0% of the group could communicate in Norwegian, and 22.2% held employment, though on sick leave at treatment start. None was engaged in formal studies. One participant lived in a refugee reception centre. The others lived in ordinary flats in the community. Two persons did not hold a Norwegian citizenship or a non-time-limited permission to stay in Norway. Two of the participants had completed secondary education in Norway [12]. See Table 1 for demographics and scores on mental health, QOL, host country language competence and work/study status upon entering the study.

Table 1. Demographics, mental health symptoms, quality of life, and indicators of functioning in exile upon entering therapy and the study.

Variables N M (SD) Percent (n)
Demographics:
Male gender 54 64.8 (35)
Age (years) 54 39.3 (8.2)
Married/Cohabitating 54 64.8 (35)
Participants with children 54 81.5 (44)
Years of education in country of origin 54 9.7 (4.5)
Years living in Norway 54 10.5 (6.5)
Experienced childhood traumaa 54 91.7% (49)
HTQ-Trauma Eventsb 54 16.3 (6.3)
Symptoms:
PTSD-Totalc 52 2.82 (.47)
PTSD-Reexperiencingc 52 2.89 (.69)
PTSD-Arousalc 52 3.12 (.49)
PTSD-Avoidancec 52 2.56 (.57)
Anxietyd 53 2.89 (.59)
Depressiond 53 2.94 (.54)
Diagnostic level of symptoms:
PTSD (clinical cutoff ≥2.5)c 52 78.9 (41)
Anxiety (clinical cutoff >1.75)d 53 96.2 (51)
Depression (clinical cutoff >1.75)d 53 98.1 (52)
Quality of life
Physical Healthe 52 28.5 (13.8)
Psychological Healthe 52 25.6 (15.9)
Social Relationshipse 52 36.6 (23.4)
Environmente 52 45.2 (40.1)
Indicators of functioning in exile:
Communicated in Norwegian 54 50.0 (27)
Employed or studying 54 22.2 (12)

aPercentage and number of participants who reported childhood adverse events [12].

bHarvard Trauma Questionnaire, Part 1 [58]: List of 37 types of experiences related to war, persecution and human rights violations, each confirmed experience is scored 1.

cHTQ-Part IV [58], 16 items, presence and severity of item/symptom scored 1 (not at all) to 4 (extremely)

dHSCL-25 [58], also scored 1 (not at all) to 4 (extremely).

eWHOQOL-Bref [59], 26 items, quality of life for each item scored 0 (very poor) to 100 (excellent).

Procedures

For the study, we collaborated with two outpatient clinics and six psychotherapists with publicly funded, independent practices, all part of the specialist mental health services in Norway. During the 3-year intake period in these services, all patients who were eligible according to the inclusion criteria, were asked to participate in the study. Potential participants were carefully informed, in writing and verbally, about the purpose of the study, about confidentiality, that participation in the study was voluntary, that rejecting was of no consequence for their treatment, and that, if they signed up for the study, they could withdraw at any time. Seventy-two patients were asked to participate in the study, and 54 accepted and gave their written consent (75% inclusion).

The participants were interviewed face-to-face throughout the study by two researchers who were also clinical specialists, and who were external to the services where the participants received their therapy. Information on the language ability of participants was provided by the mental health clinics, and interpreters were summoned accordingly. For participants who were expected to master the Norwegian language (or English), we arranged a first meeting without an interpreter, but if mutual understanding and expressive capacity in a common language was not sufficient, the meeting was rescheduled, and later research interviews were conducted with the help of an interpreter. In later years of the study, interpreters were cancelled if participants demonstrated increased Norwegian skills by understanding and responding to our questions and comments in Norwegian before the interpreter had time to translate.

The participants were assessed with quantitative and qualitative methods, including symptom checklists and quality of life questionnaires, structured interviews assessing personality functioning and attachment history (Rorschach and Adult Attachment Interview), and open-ended qualitative interviews about past and present aspects of their lives. As recommended by Mollica et al. [58], the checklists and questionnaires were completed in the presence of the researchers, who offered assistance and explanations when needed, and who listened and responded in an atmosphere of empathy. Most of the participants preferred that researchers read the questionnaire and checklist items to them and noted their responses.

At inclusion into the study, interviews were conducted over 5–6 sessions (7–10 full hours) in order to complete all the planned parts of the assessment. The appointments to the research interviews were free of charge, while payment for therapy sessions in the treatment unit followed ordinary rules. In agreement with the participants, the treatment unit was informed about the results of the study intake assessment. Number of research follow-ups depended on the participants’ length of treatment and their continued response to and acceptance of invitations to participate in research interviews after termination. Mental health symptoms (symptoms of PTSD, anxiety and depression) and quality of life (QOL, four domains) were thus recorded several times, about yearly or bi-yearly, and then more infrequently, before, during, at the end of, and after therapy. The participants were included into the study over a three-year period (2006–2009), and follow-up assessments were performed at varying times and frequencies between the participants. At each follow-up, one, two, or more meetings were required, depending on the respondent’s health status, extensiveness of their responses, and the use of an interpreter. Therapists were also interviewed about their professional background, their experience working with refugees, and about the specific therapy process with the patient participating in the study.

Treatment

Treatment consisted of psychological therapies of various lengths and theoretical orientations, including trauma-directed and psycho-social interventions, and was provided mostly by specialists in clinical psychology (58.8%) and psychiatry (25.5%), in the outpatient clinics also by a few psychologists and medical doctors in specialist training, and a couple of social workers and nurses with specialization in psychotherapy. The therapies in the outpatient clinics mostly had a one to two year limit, while therapists in independent practices could offer longer-term psychotherapy. The longer lasting psychotherapies in this study were mainly relational in orientation, working with alliance, relational safety, and with the traumatic experiences themselves. Each patient had to pay co-payments adding up to equivalent to 240 Euro at the beginning of each year of treatment. The rest of the year treatment was free of charge.

Instruments/measures

The Harvard Trauma Questionnaire -Trauma Events (HTQ, Part 1; [58]), is a checklist of potentially traumatic experiences (PTEs) related to war, persecution, and other human rights violations (HRVs). The revised Cambodian version was modified, as recommended by Mollica et al., to encompass the PTEs most relevant to the group in question–here, a multinational sample. Our list thus consisted of 37 different types of PTEs related to war and HRVs such as armed attacks, persecution, and lethal danger, killings of loved ones, imprisonment, and torture. There were no age requirements to scoring of these experiences. Each confirmed type of experience is scored 1.

The Harvard Trauma Questionnaire, Symptoms of PTSD (HTQ, Part IV, Questions 1–16) [58], is a symptom checklist consisting of 16 items derived from the criteria for PTSD in the Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) [60], which was the edition in use when this study started. The presence and severity of each item/symptom is scored from 1 (not at all) to 4 (extremely). Mollica et al’s [58] validation study resulted in a clinical cutoff of ≥ 2.5, with a sensitivity of 78% and a specificity of 65% for PTSD. Scores ≥ 2.5 were considered checklist positive for PTSD. The mean of all 16 items (PTSD-Total), and the means of the three symptom clusters; PTSD-Reexperiencing (Questions 1, 2, 3, and 16), PTSD-Arousal (Questions 6, 7, 8, 9, and 10), and PTSD-Avoidance (Questions 4, 5, 11, 12, 13, 14, and 15) were used in the analyses.

The Hopkins Symptom Checklist-25 (HSCL-25 [58]) consists of 10 items tapping symptoms of anxiety (non-specific) and 15 items tapping symptoms of depression. The presence and severity of each item/symptom is scored from 1 (not at all) to 4 (extremely). Mean scores above 1.75 on the 10 items tapping anxiety and on the 15 items tapping depression was found consistent with clinically significant anxiety (generalized anxiety disorder) and major depression, respectively, with high sensitivity and specificity. Clinical cutoff was thus set to > 1.75. [58]. According to Mollica et al. [58] the HTQ and the HSCL- 25 were not designed as a self-report, but should always be administered to traumatized refugees by health care workers, in an atmosphere of empathy.

The World Health Organisation Quality of Life Bref (WHOQOL-Bref) [59, 61] consists of 26 items organized into Domain 1, Physical Health (7 items); Domain 2, Psychological Health (6 items); Domain 3, Social Relationships (3 items); and Domain 4, Environment/Environmental Conditions (8 items). Each item is scored on a Likert scale from 1 (not at all/very dissatisfied/ disagree strongly) to 5 (completely/very satisfied/agree strongly). Following the most commonly used option in the WHOQOL-Bref Manual, raw scores were converted to a scale from 0 (very poor) to 100 (excellent). A worldwide field study among rich and poor, sick and healthy individuals by Skevington et al. [61] resulted in the following means: 64.8 for Physical Health, 60.0 for Psychological Health, 57.2 for Social Relationships, and 54.0 for Environmental Conditions. (For comparison with the initial QOL mean scores of our participants, see Table 1)

Exile life functioning was represented by the variables Communicated in Norwegian, tapping whether or not Norwegian language competence was sufficient to take part in the research interviews in Norwegian, and Employed or Studying, tapping whether or not the participants held employment or were engaged in formal studies, even if on sick-leave at the time of assessment. Both were dichotomously scored 1 (yes) or 0 (no), and expressed by the percentage of participants scoring yes. The scoring of the variable Communicated in Norwegian was based on our experience in the interviews. This was a crude measure. Without our presence, explanations and examples, fewer would have been able to accurately understand and respond to the questionnaire items. The participants’ employment or student status was based on their report, and was merged into one variable. We see exile language acquisition, ability to work and study as partly dependent on a tolerable level of anxiety and intrusive thoughts, and thus possible signs of increased mental well-being, as well as prerequisites to function as integrated members of the society.

The number of therapy sessions and treatment length in years, were calculated from information in the treatment records and from therapists’ reports in our interviews with them. When there was more than one treatment episode during the study, the sessions and months in each of the treatments were added.

Statistical procedures

Descriptive analyses were included for research participation, questionnaire completion, and treatment dose. The outcomes studied during follow-up included posttraumatic stress symptoms, anxiety and depression symptoms, and QOL in four domains assessed through the 10 years of follow-up. Also included were two areas of exile life functioning, the variables Communicated in Norwegian (ability to take part in the research interviews in Norwegian) and Employed or Studying (holding employment or a student status). Changes from intake to the situation at the last research contact were investigated by exact McNemar tests. To examine changes in mental health symptoms and QOL, including all measures obtained at different times and intervals for the 54 participants over the 10 years of study, we used linear mixed effects (lme). lme is a statistical method suited to analyse repeated measurements in longitudinal studies, even when number of observations and the observation times differ among subjects [62, 63]. Time was modelled as continuous from T1. All measures over the entire research period were utilized to estimate the progress. Missing data were left missing. Random effects were included for intercept and slope, and the random structure was simplified as recommended by Pinheiro and Bates [63], if confidence intervals for random effects were not estimable or confidence limits were severely small or large. Thus, for QOL Environmental Conditions, the random structure had to be simplified by including random variation for the intercept only. Analyses of changes in symptoms of PTSD, anxiety, depression and QOL over time were performed. Marginal R2 was computed as a measure of effect size for general linear mixed effects models by a method developed by Nakagawa and Schielzeth [64]. Marginal R2 is defined as the proportion of variance attributed to the fixed factors, compared with the sum of variances for random effects. Further, we computed an effect size measure r defined as the square root of the marginal R2. Cohen’s [65] benchmarks were used to evaluate the effect sizes: a correlation coefficient r = .10 represented a small effect, r = .30 a medium effect, and r = .50 a large effect. Descriptive statistics and t-tests were analysed by IBM SPSS Statistics, version 26. Mixed effects models were analyzed by the R package nlme and exact McNemar tests by the R package exact 2x2 [66].

Results

Descriptives

Fifty-four participants met for the intake interviews. One of them did not wish to respond to the questionnaires at intake, but did so at later follow-ups. During the first three years of follow-up, we only lost three participants from the study; and among these three, we were able to obtain information on language and work status for one of them about three years after intake [57]. Almost three fourths (74.1%) of the participants chose to continue taking part in the study after three years, when participants were asked for a renewed written consent. After this time, research participation dropped little by little, usually some time after therapy termination. When data collection was terminated in 2017, participants’ total time taking part in the study was from 1 year up to 10.9 years (We have rounded down to 10 years in description of the study because only two participants took part in the study more than 10.49 years. Mean duration of participation in the study was 5.2 years (SD = 2.7). One third of the participants (33.3%) took part in the study for six or more years. One participant met with us only at one assessment-point, seven participants met only at two assessment points, 41 participants met with us at three to five assessment-points, and 5 participants met with us at six to seven assessment points. Over the entire study, the researchers spent from about 12 to 24 full hours interviewing each participant.

Questionnaire completion: Over the years, 54 participants completed altogether 201 HSCL-25 questionnaires, tapping anxiety and depression, varying from 1 to 7 times each between the participants, with a mean of 3.7 times each. Due to lack of endurance, time restraints and prioritizing of the qualitative aspects of the main study, the participants responded slightly less to the other questionnaires; 54 participants completed 160 HTQ Part IV questionnaires (varying from 1 to 7 times, with a mean of 3.0 times each), tapping symptoms of PTSD, and 53 participants completed 156 WHOQOL-Bref questionnaires (varying from 1 to 7 times, with a mean of 2.9 times each), tapping four domains of quality of life. The follow-up assessments over the 10 years of study were obtained at different times and frequencies, i.e. were not synchronized between participants, and can therefore not be shown in a table.

Among the refugee patients, 34 started in the outpatient mental health clinics, and 20 in individual psychotherapy practices with public funding. For some participants, research follow-up some time after termination of treatment in the outpatient clinics showed that participants were still greatly suffering, and often they were not admitted for further therapy in the outpatient clinics. The researchers were then able to allocate some to individual practitioners. This included six of the participants.

Mean length of the participants’ therapies during the whole study period was 61.3 sessions (SD = 74.5) over 3.4 years (SD = 3.1). Among the participants, 31.5% had 1 year of treatment or less, 22.6% had 6 years of treatment or more. Furthermore, 24.1% (n = 13) of the participants had less than 11 sessions, 38.9% (n = 21) had more than 45 sessions, and 25.9% of the participants had 100 or more sessions. The few patients terminating therapy after only a few sessions had various reasons for this. In a qualitative interview, one of these patients told that he terminated his contact with the therapist in the specialist service, as he felt sufficiently helped by the T1 research interviews. A couple of patients terminated prematurely for economic reasons, but took part in research interviews, which were free of charge. Some of the therapists, especially in the “private” practices, were able to keep on working with their patients for several years, in the hope that a fuller recovery would be possible. An ad hoc computation of the relationship between length of research contact and length of treatment showed that participants with longer treatments also took part in research follow-ups over a longer period of time (r = .536, p < .001).

Changes in mental health and quality of life

The mixed effects analyses showed that over time, the participants improved significantly in symptoms of PTSD, anxiety and depression, and in three aspects of QOL. Among them, significance ranged from p ≤ .001 to p = .030, and effect sizes ranged from r = .05 to r = .38. The effect sizes were small for all the symptom changes (r = .05 to .13) and for the QOL variables Social Relationships (r = .07) and Environmental Conditions (r = .13), while the changes in the QOL variables Psychological Health (r = .38) and Physical Health (r = .32) were of medium effect size (see Table 2).

Table 2. Changes in symptoms and quality of life over the 10-year follow-up.

Estimate (95% CI) p PP t (df) R2 r
Symptoms:
PTSD-total -0.03 [-0.04, -0.01] .003 -0.87 -3.03 (105) .003 .05
PTSD-Reexperiencing -0.03 [-0.05, -0.01] .004 -0.93 -2.94 (105) .003 .05
PTSD-Arousal -0.03 [-0.05, -0.01] .001 -1.08 -3.28 (105) .006 .08
PTSD-Avoidance -0.02 [-0.04, -0.00] .030 -0.70 -2.21 (105) .007 .08
Anxiety -0.03 [-0.04, -0.01] < .001 -0.97 -3.77 (146) .016 .13
Depression -0.03 [-0.05, -0.01] < .001 -0.97 -3.50 (146) .006 .07
Quality of Life:
Physical Health 0.96 [0.50, 1.41] < .001 0.96 4.18 (102) .102 .32
Psychological Health 1.19 [0.67, 1.71] < .001 1.19 4.53 (102) .148 .38
Social Relationships 0.30 [-0.42, 1.01] .411 0.30 0.83 (102) .005 .07
Environment 0.42 [0.05, 0.79] .025 0.42 2.28 (102) .017 .13

Linear mixed effects analyses including results from 160 completed HTQ-PTSD symptom checklists, 201 completed HSCL-25 anxiety and depression checklists and 156 completed WHO Quality of Life questionnaires from the 54 participants over the research period. Estimate (fixed effects coefficient) = difference in outcome per time unit (= 0.5 years). PP = Estimate transformed to percentage points (100 x estimate/range of the outcome scale). R2 was computed by Nakagawa and Schielzeth’s method [64] for obtaining marginal R2 from generalized linear mixed effects models. r (effect size) = square root of the marginal R2. Negative values for mental health symptoms and positive values for quality of life represent improvement.

The lme modelled linear trajectories. Non-linearity was checked, but there were no clear indications of non-linear trajectories (see S1 Fig). At intake, 78.9% (n = 41) qualified for a PTSD diagnosis, 96.2% (n = 51) for an anxiety diagnosis, and 98.1% (n = 52) for major depression, while at the last meeting with each of the participants, 59.3% (n = 32) qualified for a PTSD diagnosis, 81.5% (n = 44) for an anxiety diagnosis, and 85.2% (n = 46) for major depression, according to the clinical cutoff of the symptom checklists (see Table 1, S1 and S2 Data).

The trajectories of symptom improvement in PTSD Total, PTSD Reexperiencing, PTSD Arousal, PTSD Avoidance, Anxiety, and Depression are illustrated in Fig 1.

Fig 1. Improvement in mental health symptoms over time.

Fig 1

All reductions in symptoms were significant. Symptoms of PTSD were measured by the Harvard Trauma Questionnaire (HTQ Part IV) [63]. Anxiety and Depression were measured by the Hopkins Symptom Checklist (HSCL-25) [63]. The plot illustrates the trajectories over 10 years from study inclusion/treatment start.

The participants’ improved quality of life is illustrated by the trajectories of the four domains in Fig 2.

Fig 2. Improvement in quality of life over time.

Fig 2

Improvements in Quality of Life were significant in the domains Physical Health and Psychological Health (p < .001), and Environment (p = .025). Quality of Life: WHOQOL-Bref [65]. The plot illustrates the trajectories over 10 years from study inclusion/treatment start.

Changes in exile life functioning

The last time each of the 54 participants met with us, 9 more participants (5 females, 4 males) could communicate in Norwegian during interviews, and 8 more of the participants (2 females, 6 males) had gotten employed or started studying during follow-up. However, one participant stopped working due to increasing mental health problems. Thus, the number of participants who could communicate in Norwegian increased significantly (p = .004) from 50.0% (n = 17) to 66.7% (n = 36), and the number of participants who were engaged in paid work or formal studies increased significantly (p = .039) from 22.2% (n = 12) at intake to the study, when all of 12 who held work were on sick-leave, to 35.2% (n = 19) at our last meeting. None of them were at this point on sick-leave. A supplementary independent samples t-test of the difference in “Length of stay in Norway at our last meeting” between those who changed from not being able to communicate in Norwegian at the beginning of the study to being able to communicate in Norwegian at our last meeting, and those who did not change status concerning language competence, revealed a significant difference of about six years (p = .003), indicating that the shorter the stay in Norway, the greater the likelihood of a change from not being able to communicate in Norwegian to being able to do so. A corresponding supplementary independent samples t-test of the difference in “Length of stay in Norway at our last meeting” between those who changed from not being employed or enganged in formal studies at the beginning of our study to having gotten employed or entered formal studies at our last meeting. revealed no significant difference (p = .598). However, an ad hoc exact chi-square test showed that 44.4% of those who learned to communicate during the study, also got employed or started in formal studies, and 50% of those who got employed or started in formal studies had also learned to communicate in Norwegian during the course of the study (p = .033).

Discussion

With repeated interviews and assessments over 10 years, this study examined the mental health trajectories of 54 (former) patients with refugee background and trauma related mental health disorders. The research interviews started at the time of the participants’ entrance into psychological treatment, continued through their time attending treatment, and followed up through variable lengths of time after termination. The therapies were of differing lengths and theoretical approaches, but all addressed to some extent the patients’ traumatic experiences. The mean duration of the therapies was 61 sessions over about three years. Although most therapies were planned as weekly, the average, holidays deducted, turned out to be roughly two sessions per month. According to the therapists, some patients cancelled sessions for physical health reasons, some to follow family members to various appointments, and some were absent without notice due to having forgotten sessions or overslept after sleepless nights.

The linear mixed effects analyses including measurements over the entire research period, demonstrated that the participants’ long-time improvement, at the mean level, was significant but modest in symptoms of PTSD, anxiety and depression. Moreover, the participants improved significantly, and more decisively, in subjectively felt quality of life in the psychological and physical health domains. The linear mixed effects results may not be reliable during late follow-up since only a small group of participants had long follow-up times. Many of these received long-term therapy. The substantial uncertainty during late follow-up can also be seen from the size of the grey, trumpet-like shadows on the smooth curves towards the 10-year mark [S1 Fig]. We found significant improvement in exile life functioning among the participants, in terms of the number of participants who, at the end of follow-up, could communicate in Norwegian and in the number who were employed or had entered formal studies.

The modest symptom improvement can be attributed to the protracted, severe, and complex condition of the refugee patients at treatment start. In the introduction, we reported on the chronic trajectories of many refugee patients. The mean duration of residence in Norway when entering treatment and this study, was 10.5 years. Many clinical studies, in addition to ours, have found that refugee participants have stayed for several years–with means from five up to 16 years–in the host country before entering mental health treatment [27, 67]. The late entrance to mental health services may be part of the reason for the chronicity of many of these patients’ mental health disorders, despite therapy. According to the findings by Haagen et al. [49], another factor contributing to the modest improvement, may be the high level of comorbid depression at treatment start. Comorbidity and psychosocial problems in general clinical populations predict poorer treatment response, and among patients with complex presentations of PTSD, with comorbidity, and with chronic conditions at the outset of therapy, many continue to have substantial symptoms after termination [46, p. 174]. Thus, the longitudinal, small, average symptom reduction found in this study may be as good as it gets, considering the complexity and chronicity of many of these patients’ mental health disorders in combination with psychosocial problems and an often marginalized position in society.

Concerning the participants’ mental health changes, symptoms of anxiety decreased the most, then the arousal and avoidance clusters of PTSD, thereafter depression. The reduction in symptoms was lowest within the reexperiencing cluster of PTSD. This implies that even if the participants were still bothered by recurring thoughts related to the traumatic events, reexperiencing did not evoke as much anxiety. The decrease in arousal and avoidance can be interpreted in the same direction: trauma memories persist, or are easily evoked, but the participants do not engage in as much avoidance behaviour, and there is not as much evidence of bodily or emotional upheaval. The decrease in depression can be understood as a sum effect of general symptom improvement and improved functioning. Even if the changes are of small effect, these seem to be important results. However, as noted by Lambert [46], symptom reduction may not be the most important sign of improvement with severely traumatized patients and may not be the best way to evaluate outcome. Furthermore, for this patient group, a full recovery in terms of symptom removal may not be a realistic treatment goal. The greater effect size of improvement in quality of life relative to symptom reduction among the participants in this study could indicate that the participants coped with their symptoms with greater strength or less suffering.

The participants’ perceived quality of their psychological health improved the most, but was closely followed by their subjectively felt quality of physical health. The joint initial low level of, and subsequent joint improvement in the participants’ experience of the quality of their psychological and their physical health indicates the close relationship between physical and psychological well-being, and resonates well with the finding by e.g. Berthold et al. [21], of the connection between physical and mental health problems among refugees. The participants’ perceived quality of their environmental conditions improved somewhat less, but then their initial score was not as low as other aspects of quality of life at intake to the study–“probably owing to the relatively good welfare system in Norway” [57, p. 40]. Finally, the participants’ subjective experience of their quality of social relationships also improved, although less than other aspects of quality of life. Our impression from the qualitative interviews was that many of our informants struggled with relating socially to anyone outside the immediate family. A separate study of children in refugee families, including several children of participants in this study, showed that the children took much responsibility for parents’ social function, including relations outside the family [68, 69]. Among the adult participants in the present study, however, some appeared to become more socially confident after the benign experience of talking with their therapist, and when the pressure of their trauma-related and depressive ruminations decreased.

The significant increase, during the study, in the number of participants who could communicate in Norwegian during interviews, was, according to the supplementary analysis, partly related to being newer in the country, so that some more years of stay made a positive difference. Other not-investigated factors must also have been of importance to the result. The increase in the number of participants who were employed or engaged in formal studies was also significant. Here, the supplementary analysis showed no significant association between change in job/study status and number of years spent in Norway. It may be worth noting that in addition to the relatively small increase in participants who became employed or started studying, all except one of those who already held employment (although on sick-leave) when they entered treatment and the study, managed to get back to work and stay employed. Our belief is that therapy was important to take the step into employment or studies, as well as recuperating and holding onto jobs. Considering the participants’ mean age of nearly 40 years, their mean decade long stay in Norway, and their likely chronic mental health condition at entry to therapy and the study, the results are relatively encouraging. The improvement in exile life functioning together with the improved quality of life, may demonstrate that even small effect changes in symptoms can have important consequences for the participants’ lives. According to Schick et al.’s [31] proposal of a circular association between mental health, wellbeing, and exile life functioning, positive change in any of these areas may also fuel improvement in other areas.

Not as easily measured as items on a checklist, but supported by our impressions from the qualitative interviews, we believe that the contact over time with a benign, empathising and interested therapist gives hope, alleviates stress, encourages the patient to move on in life, and thus contributes to increased tolerance of symptoms, greater well-being, and improved functioning.

In the participants’ therapies, the number of therapy sessions was not set in advance, but was dependent in part by each participant’s needs and course of improvement. In the mental health outpatient clinics participating in this study, few patients were allowed more than 1–2 years of treatment. The individual practice specialists, however, could work with their patients over several years. The results showed that about one fourth of the participants had less than 11 therapy sessions, a non-therapeutic number of sessions according to the studies of Lambert and of Hansen et al. [47, 48]. On the other hand, almost 39 percent of the patients had more than 45 sessions, the minimum number of sessions that were estimated to be required for improvement among patients with comorbid disorders and psychosocial problems [47, 48]. In our study, nearly 26 percent of the participants had 100 or more therapy sessions, a number of sessions that will only infrequently be offered to refugee patients in Norway, and probably also in most other countries. We have not examined the relationship between therapy dose (number of sessions) and improvement in mental health symptoms and QOL in the present study. In general, there is little correlation between number of sessions and outcome, as discussed in the introduction [46]. However, from the qualitative interviews with patients and with their therapists, we could see that for some patients, the long-term therapy over several years resulted in great steps forward, while for others, their suffering seemed to be as severe when the therapy was terminated. Still, one of the patients, who after many years of therapy seemed not to have progressed, said to his therapist in the last session: “You have helped me much more than you think”. In line with De Smet et al. [50] we suggest that discerning what constitutes good treatment and beneficial outcome for this patient group warrants closer study.

The changes observed in this study may be attributed to a combined effect of the personal qualities of the participants, the therapy experience, including the therapist’s personal qualities, therapeutic style, and interventions, the match between therapist and patient, the comprehensive research interviews, experienced by many of the participants as therapeutic in themselves, life events outside therapy, and the passing of time. We tentatively refer to the previously offered suggestion [57, p. 56], that the long stay in Norway, the longevity of functional impairment, and the severe load of anxiety, depression and posttraumatic stress symptoms upon entering therapy, makes it unlikely that significant improvement during the next years was due to time alone.

The significant improvements found over the entire 10 years of data collection, indicated that gains obtained at the three-year follow-up [56] were more or less maintained. However, we observed extensive individual differences in treatment response/long-term outcome among the participants at the end of the study, and many of the participants still had a high symptom burden. Therefore, predicting who in refugee patient groups can benefit from therapy in general, and long-term treatment in particular, may be difficult. Nevertheless, leaning on a conclusion by Bager et al. [70] about the positive family level cost-benefit effect of psychosocial rehabilitation for severely traumatized refugees, we consider it well worth the effort to invest in the wellbeing of the individual patient, with the anticipated spin-off effect upon the patient’s spouse and children.

Strengths and limitations

This study, with its longitudinal design including several outcome measures, may contribute to knowledge regarding the long-term course during and after psychological treatment, of traumatized refugees’ mental health, well-being and functioning in exile. The broad inclusion criteria and the high acceptance rate in the study imply that the participants can be seen as representative of the clinical population of trauma-affected refugees being accepted for psychological treatment in and around the Oslo area of Norway at the time of inclusion. The patients received treatment of varying theoretical orientations and lengths, according to the patients’ needs, the therapists’ appraisal of appropriateness and effect, and the policy of the treatment units.

A limitation of the study is that we did not perform a pre-study power calculation in 2006. Furthermore, without a controlled design, we cannot claim that any positive changes can be attributed to the treatment received. However, the participants’ mean stay in Norway was more than 10 years when they entered the study, indicating increased or continued suffering rather than improvement over time. Likewise, the long duration of follow-up, with repeated measurements, and the statistical method employed, which made use of all the measuring points, speak against the notion that we might have captured a top in suffering at inclusion, and at later measurements a bottom of the wavelike ups and downs of mental health suffering found in refugee studies. A limitation is that using linear mixed effects analysis did not allow us to see when changes appeared, as they were modelled linearly. The great variation in national origins, time of stay in Norway, length and type of therapy, and number and frequencies of research follow-ups, limit what analyses can be made and what conclusions can be drawn. We have not yet examined the trajectories of different subgroups among the participants, for example of the third among the participants who continued to take part in research assessments the last few years. Looking into this subgroup could inform us whether they were among cases with less or more improvement, causing the long-term mental health trajectory to inflate or deflate.

The participants did not respond to all the questionnaires at each point in time. We may have wanted to do too much at each research meeting with the refugees. Due to the participants’ many strains of living, their difficult social situation, and their mental and physical problems, many of the participants did not have the time or strength to respond to all of the questionnaires and the semi-structured qualitative interview questions each time. Many preferred to talk freely about their life situation and experiences.

Conclusion and implications

During this 10-year follow-up study, the traumatized refugees had attended psychotherapy of varying length and content in publicly funded, specialist mental health services in Norway. The participants improved significantly and modestly in mental health symptoms, but more in experienced quality of psychological and physical health. Thus, how one lives with ones symptoms may be more important than the level of symptoms themselves. Some were able to start formal education, some who had not previously been employed, started working, and some learned to communicate in Norwegian during the course of the study. The results hide substantial individual variation in improvement. As evidenced in the quantitative data and our repeated meetings with the participants, some benefited to a great extent, others moderately, and a few, left untouched by the therapy experience, just continued on a downwards spiral. Discerning which characteristics impact on the degree of benefit from psychotherapy, and which barriers may be at play for those who do not seem to benefit, is vital to be able to help as many of these patients as possible and to use existing resources in a good way. Major symptom reduction may not be attainable, and may not be the most important indication of long-term improvement among refugees with long-standing and trauma-related suffering. In addition to symptoms mitigation, evaluation of treatment effects should take into consideration a broad array of outcomes, including physical and psychological well-being, exile life functioning, relational security, and social network. Furthermore, individuals or subgroups should be studied in detail to learn more about factors related to change.

Preventive efforts and mental health interventions at an earlier time, as in a stepped care approach [71, 72], could counteract the chronicity of mental health suffering in this at-risk group. For refugees in need of mental health treatment, we suggest that working simultaneously with mental health problems, host language acquisition, and employment may increase gains and benefit all of these areas. Finally, in accordance with Hynie [29] we propose that the whole person, embedded in his or her familial and societal context, and examination of ongoing stress factors that need to be alleviated, should be included in approaches to promote health and restore functioning for traumatized refugees.

Supporting information

S1 Fig. Smooth curves to check for non-linearity.

(PDF)

S1 Data. HTQ PTSD datafile.

(SAV)

S2 Data. HSCL-25 anx_depr datafile.

(SAV)

S3 Data. WHOQOL qol datafile.

(SAV)

S4 Data. LanguageWorkStudy datafile.

(SAV)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Bogic M, Njoku A, Priebe S. Long-term mental health of war-refugees: a systematic literature review. BMC Int Health Hum Rights. 2015; 15: 29 10.1186/s12914-015-0064-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fazel M, Wheeler J, Danesh J. Prevalence of serious mental disorder in 7000 refugees resettled in western countries: A systematic review. Lancet. 2005; 365: 1309–1314. 10.1016/S0140-6736(05)61027-6 [DOI] [PubMed] [Google Scholar]
  • 3.Li SSY, Liddell BJ, Nickerson A. The Relationship between post-migration stress and psychological disorders in refugees and asylum seekers. Curr Psychiatry Rep. 2016; 18: 82 10.1007/s11920-016-0723-0 [DOI] [PubMed] [Google Scholar]
  • 4.Vaage AB, Thomsen PH, Silove D, Wentzel-Larsen T, Van Ta T, Hauff E. Long-term mental health of Vietnamese refugees in the aftermath of trauma. Br J Psychiatry. 2010; 196: 122–125. 10.1192/bjp.bp.108.059139 [DOI] [PubMed] [Google Scholar]
  • 5.Statistics Norway, 2008. https://www.ssb.no/en/befolkning/statistikker/flyktninger/aar/2008-09-15
  • 6.Bäärnhielm S, Laban K, Schouler-Ocak M, Rousseau C, Kirmayer LJ. Mental health for refugees, asylum seekers and displaced persons: A call for a humanitarian agenda. Transcult Psychiatry. 2017; 54: 565–574. 10.1177/1363461517747095 [DOI] [PubMed] [Google Scholar]
  • 7.Simich L, Andermann L, editors. Refuge and Resilience: Promoting resilience and mental health among resettled refugees and forced migrants (Vol. 7). Dordrecht, the Netherlands: Springer; 2014. [Google Scholar]
  • 8.Papadopoulos RK. Refugees, trauma and Adversity-Activated Development. Eur J Psychother Couns. 2007; 9: 301–312. 10.1080/13642530701496930 [DOI] [Google Scholar]
  • 9.Southwick SM, Bonanno GM, Masten AS, Panter-Brick C, Yehuda R. Resilience definitions, theory, and challenges: interdisciplinary perspectives. Eur J Psychotraumatol. 2014; 5: 25338 10.3402/ejpt.v5.25338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hollifield M, Warner TD, Krakow B, Westermeyer J. Mental Health Effects of Stress over the Life Span of Refugees. J Clin Med. 2018; 7, 25 10.3390/jcm7020025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pumariega AJ, Rothe E, Pumariega JB. Mental Health of Immigrants and Refugees. Community Ment Health J. 2005; 41: 581–597. 10.1007/s10597-005-6363-1 [DOI] [PubMed] [Google Scholar]
  • 12.Opaas M, Varvin S. Relationships of childhood adverse experiences with mental health and quality of life at treatment start for adult refugees traumatized by pre-flight experiences of war and human right violations. J Nerv Ment Dis. 2015; 203: 684–695. 10.1097/NMD.0000000000000330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Riber K. Trauma complexity and child abuse: A qualitative study of attachment narratives in adult refugees with PTSD. Transcult Psychiatry. 2017; 54: 840–869. 10.1177/1363461517737198 [DOI] [PubMed] [Google Scholar]
  • 14.Courtois CA. Complex trauma, complex reactions: Assessment and treatment. Psychotherapy: Theory, research, practice, training. 2004; 41: 412–425. [Google Scholar]
  • 15.Briere J, Scott C. Complex trauma in adolescents and adults. Effects and treatment. Psychiatr Clin North Am. 2015; 38: 515–527. 10.1016/j.psc.2015.05.004 [DOI] [PubMed] [Google Scholar]
  • 16.Anda RF, Felitti VJ, Bremner JD, Walker JD, Whitfield C, Perry BD, et al. The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology. Eur Arch Psychiatry Clin Neurosci. 2006; 256: 174–186. 10.1007/s00406-005-0624-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Carlsson J, Sonne C, Silove D. From pioneers to scientists: challenges in establishing evidence-gathering models in torture and trauma mental health services for refugees. J Nerv Ment Dis. 2014; 202: 630–637. 10.1097/NMD.0000000000000175 [DOI] [PubMed] [Google Scholar]
  • 18.Pavli A, Maltezou H. Health problems of newly arrived migrants and refugees in Europe. J Travel Med. 2017; 24 10.1093/jtm/tax016 [DOI] [PubMed] [Google Scholar]
  • 19.van Melle MA, Lamkaddem M, Stuiver MM, Gerritsen AA, Devillé WL, Essink-Bot ML. Quality of primary care for resettled refugees in the Netherlands with chronic mental and physical health problems: A cross-sectional analysis of medical records and interview data. BMC Fam Pract. 2014; 15: 160 10.1186/1471-2296-15-160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.El Sount CRO, Windthorst P, Denkinger J, Ziser K, Nikendei C, Kindermann D, et al. Chronic pain in refugees with posttraumatic stress disorder (PTSD): A systematic review on patients' characteristics and specific interventions. J Psychosom Res. 2019; 118: 83–97. 10.1016/j.jpsychores.2018.07.014 [DOI] [PubMed] [Google Scholar]
  • 21.Berthold SM, Kong S, Mollica RF, Kuoch T, Scully M, Franke T. Comorbid mental and physical health and health access in Cambodian refugees in the US. J Community Health. 2014; 39: 1045–1052. 10.1007/s10900-014-9861-7 [DOI] [PubMed] [Google Scholar]
  • 22.Teodorescu DS, Heir T, Siqveland J, Hauff E, Wentzel-Larsen T, Lien L. Chronic pain in multi-traumatized outpatients with a refugee background resettled in Norway: a cross-sectional study. BMC Psychol. 2015; 3: 7, 1–12. 10.1186/s40359-015-0064-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Momartin S, Silove D, Manicavasagar V, Steel Z. Comorbidity of PTSD and depression: associations with trauma exposure, symptom severity and functional impairment in Bosnian refugees resettled in Australia. J Affect Disord. 2004; 80: 231–238. 10.1016/S0165-0327(03)00131-9 [DOI] [PubMed] [Google Scholar]
  • 24.van Wyk S, Schweitzer R, Brough M, Vromans L, Murray K. A longitudinal study of mental health in refugees from Burma: The impact of therapeutic interventions. Aust N Z J Psychiatry. 2012; 46: 995–1003. 10.1177/0004867412443059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Leiler A, Bjärtå A, Ekdahl J, Wasteson E. Mental health and quality of life among asylum seekers and refugees living in refugee housing facilities in Sweden. Soc Psychiatry Psychiatr Epidemiol. 2019; 54: 543–551. 10.1007/s00127-018-1651-6 [DOI] [PubMed] [Google Scholar]
  • 26.Teodorescu DS, Siqveland J, Heir T, Hauff E, Wentzel-Larsen T, Lien L. Posttraumatic growth, depressive symptoms, posttraumatic stress symptoms, post-migration stressors and quality of life in multi-traumatized psychiatric outpatients with a refugee background in Norway. Health Qual Life Outcomes. 2012; 10: 1–16. 10.1186/1477-7525-10-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Huijts I, Kleijn W, Van Emmerik A, Noordhof A, Smith A. Dealing with man‐made trauma: The relationship between coping style, posttraumatic stress, and quality of life in resettled, traumatized refugees in the Netherlands. J Trauma Stress. 2012; 25: 71–78. 10.1002/jts.21665 [DOI] [PubMed] [Google Scholar]
  • 28.Kounou KB, Brodard F, Gnassingbe A, Dogbe Foli AA, Sager JC, Schmitt L, et al. Posttraumatic stress, somatization, and quality of life among Ivorian refugees. J Trauma Stress. 2017; 30: 682–689. 10.1002/jts.22244 [DOI] [PubMed] [Google Scholar]
  • 29.Hynie M. The Social Determinants of Refugee Mental Health in the Post-Migration Context: A Critical Review. Canad J Psychiatry. 2018; 63: 297–303. 10.1177/0706743717746666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Teodorescu DS, Heir T, Hauff E, Wentzel-Larsen T, Lien L. Mental health problems and post‐migration stress among multi‐traumatized refugees attending outpatient clinics upon resettlement to Norway. Scand J Psychol. 2012; 53: 316–332. 10.1111/j.1467-9450.2012.00954.x [DOI] [PubMed] [Google Scholar]
  • 31.Schick M, Zumwald A, Knöpfli B, Nickerson A, Bryant RA, Schnyder U, et al. Challenging future, challenging past: the relationship of social integration and psychological impairment in traumatized refugees. Europ J Psychotraumatology 2016; 1–9. 10.3402/ejpt.v7.28057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Salvo T, Williams AC. “If I speak English, what am I? I am full man, me”: Emotional impact and barriers for refugees and asylum seekers learning English. Transcultural Psychiatry, 2017; 54: 733–755. 10.1177/1363461517746315 [DOI] [PubMed] [Google Scholar]
  • 33.Kartal D, Alkemade N, Kiropoulos L. Trauma and mental health in resettled refugees: mediating effect of host language acquisition on posttraumatic stress disorder, depressive and anxiety symptoms. Transcultural psychiatry. 2019; 56: 3–23. 10.1177/1363461518789538 [DOI] [PubMed] [Google Scholar]
  • 34.Slobodin O, de Jong JT. Mental health interventions for traumatized asylum seekers and refugees: What do we know about their efficacy? Int J Soc Psychiatry. 2015; 61: 17–26. 10.1177/0020764014535752 [DOI] [PubMed] [Google Scholar]
  • 35.Turrini G, Purgato M, Acarturk C, Anttila M, Au T, Ballette F, et al. Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019; 28: 376–388. 10.1017/S2045796019000027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.van Wyk S, Schweitzer RD. A systematic review of naturalistic interventions in refugee populations. J Immigr Minor Health. 2014; 16: 968–977. 10.1007/s10903-013-9835-3 [DOI] [PubMed] [Google Scholar]
  • 37.Nosè M, Ballette F, Bighelli I, Turrini G, Purgato M, Tol W, et al. Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis. PLoS ONE. 2017; 12: 2 10.1371/journal.pone.0171030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.McFarlane CA, Kaplan I. Evidence-based psychological interventions for adult survivors of torture and trauma: a 30-year review. Transcult Psychiatry. 2012; 49: 539–567. 10.1177/1363461512447608 [DOI] [PubMed] [Google Scholar]
  • 39.Thompson CT, Vidgen A, Roberts NP. Psychological interventions for post-traumatic stress disorder in refugees and asylum seekers: A systematic review and meta-analysis. Clin Psychol Rev. 2018; 63: 66–79. 10.1016/j.cpr.2018.06.006 [DOI] [PubMed] [Google Scholar]
  • 40.Halvorsen JO, Stenmark H. Narrative exposure therapy for posttraumatic stress disorder in tortured refugees: A preliminary uncontrolled trial. Scand J Psychol. 2010; 51: 495–502. 10.1111/j.1467-9450.2010.00821.x [DOI] [PubMed] [Google Scholar]
  • 41.Carlsson JM, Olsen DR, Kastrup M, Mortensen EL. Late mental health changes in tortured refugees in multidisciplinary treatment. J Nerv Mental Dis. 2010; 198: 824–828. 10.1097/NMD.0b013e3181f97be3 [DOI] [PubMed] [Google Scholar]
  • 42.Carlsson JM., Olsen DR, Mortensen EL, Kastrup M. Mental health and health-related quality of life: a 10-year follow-up of tortured refugees. J Nerv Ment Dis. 2006; 194: 725–731. 10.1097/01.nmd.0000243079.52138.b7 [DOI] [PubMed] [Google Scholar]
  • 43.Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J, Mortensen EL. The effect of flexible cognitive–behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatized refugees: pragmatic randomised controlled clinical trial. Br J Psychiatry. 2016; 208: 252–259. 10.1192/bjp.bp.114.150961 [DOI] [PubMed] [Google Scholar]
  • 44.Buhmann CB, Nordentoft M, Ekstroem M, Carlsson J, Mortensen EL. Long-term treatment effect of trauma-affected refugees with flexible cognitive behavioural therapy and antidepressants. Psychiatry Res. 2018; 264: 217–223. 10.1016/j.psychres.2018.03.069 [DOI] [PubMed] [Google Scholar]
  • 45.Hansen NB, Lambert MJ, Forman EM. The psychotherapy dose-response effect and its implications for treatment delivery services. Clin Psychol: Science and Practice. 2002; 9: 329–343. [Google Scholar]
  • 46.Lambert MJ. The efficacy and effectiveness of psychotherapy In: Lambert MJ, editor. Bergin and Garfield’s Handbook of psychotherapy and behaviour change. New Jersey: John Wiley & Sons, Inc; 2013. p. 169–218. [Google Scholar]
  • 47.Carlsson JM, Mortensen EL, Kastrup M. A Follow-Up Study of Mental Health and Health-Related Quality of Life in Tortured Refugees in Multidisciplinary Treatment. J Nerv Ment Dis. 2005; 193: 651–657. 10.1097/01.nmd.0000180739.79884.10 [DOI] [PubMed] [Google Scholar]
  • 48.Van Wyk S, Schweitzer R, Brough M, Vromans L, Murray K. A longitudinal study of mental health in refugees from Burma: The impact of therapeutic interventions. Aust N Z J Psychiatry. 2012; 46: 995–1003. 10.1177/0004867412443059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Haagen JFG, ter Heide FJJ, Mooren TM, Knipscheer JW, Kleber RJ. Predicting post-traumatic stress disorder treatment response in refugees: Multilevel analysis. Br J Clin Psychol. 2017; 56: 69–83. 10.1111/bjc.12121 [DOI] [PubMed] [Google Scholar]
  • 50.De Smet MM, Meganck R, De Geest R, Norman UA, Truijens F, Desmet M. What “Good Outcome” Means to Patients: Understanding Recovery and Improvement in Psychotherapy for Major Depression From a Mixed Methods Perspective. J Couns Psychol. 2020; 67: 25–39. 10.1037/cou0000362 [DOI] [PubMed] [Google Scholar]
  • 51.Gabriel PS, Morgan-Jonker C, Phung CMW, Barrios R, Kaczorowski J. Refugees and Health Care–The need for data: Understanding the health of government-assisted refugees in Canada through a prospective longitudinal cohort. Can J Public Health. 2011; 102: 269–272. 10.1007/BF03404047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Murray KE, Davidson GR. Review of Refugee Mental Health Interventions Following Resettlement: Best Practices and Recommendations. Am J Orthopsychiatry. 2010; 80: 576–585. 10.1111/j.1939-0025.2010.01062.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Norwegian South-East Regional Committee for Medical and Health Research Ethics. https://helseforskning.etikkom.no
  • 54.Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects World Medical Assoc; 2010. [PubMed] [Google Scholar]
  • 55.Opaas M, Hartmann E. Rorschach assessment of traumatized refugees: An exploratory factor analysis. J Pers Assess. 2013; 95: 457–470. 10.1080/00223891.2013.781030 [DOI] [PubMed] [Google Scholar]
  • 56.Opaas M, Hartmann E, Wentzel-Larsen T, Varvin S. Relationship of pretreatment Rorschach factors to symptoms, quality of life, and real-life functioning in a three-year follow-up of traumatized refugee patients. J Pers Assess. 2016; 98: 247–260. 10.1080/00223891.2015.1089247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Opaas M. Trauma, personality function, and posttraumatic reactions: a retrospective and prospective study of traumatized refugee patients. Doctoral Thesis, Dep of Psychology, University of Oslo; 2016. DUO: http://urn.nb.no/URN:NBN:no-53824
  • 58.Mollica RF, McDonald LS, Massagli MP, Silove DM. Measuring trauma, measuring torture. Instructions and guidance on the utilization of Hopkins Symptom Checklist-25 (HSCL-25) & the Harvard Trauma Questionnaire (HTQ). Harvard program in refugee trauma. 2004; CD retrieved 2006. http://hprt-cambridge.org. [Google Scholar]
  • 59.Group WHOQOL. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med. 1998; 28: 551–558. 10.1017/s0033291798006667 [DOI] [PubMed] [Google Scholar]
  • 60.American Psychiatric Association. Diagnostic and statistical manual of mental disorders Fourth edition DSM-IV. Washington, DC: American Psychiatric Association; 1994. [Google Scholar]
  • 61.Skevington SM, Lotfy M, O'Connell KA. The World Health Organization's WHOQOL-BREF quality of life assessment: Psychometric Properties and results of the international field trial. A report from the WHOQOL Group. Qual Life Res. 2004; 13: 299–310. 10.1023/B:QURE.0000018486.91360.00 [DOI] [PubMed] [Google Scholar]
  • 62.Davis CS. Statistical Methods for the Analysis of Repeated Measurements. Springer Texts in Statistics; 2002. [Google Scholar]
  • 63.Pinheiro JC, Bates DM. Linear mixed-effects models: basic concepts and examples Mixed-effects models in S and S-Plus. New York: Springer; 2000. [Google Scholar]
  • 64.Nakagawa S, Schielzeth H. A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol. 2013; 4: 133–142. [Google Scholar]
  • 65.Cohen J. A power primer. Psychol Bull. 1992; 112: 155–159. 10.1037//0033-2909.112.1.155 [DOI] [PubMed] [Google Scholar]
  • 66.The R-Foundation for Statistical Computing, Vienna, Austria, 2013.
  • 67.Keller A, Lhewa D, Rosenfeld B, Sachs E, Aladjem A, Cohen I, et al. Traumatic experiences and psychological distress in an urban refugee population seeking treatment services. J Nerv Ment Dis. 2006; 194: 188–94. 10.1097/01.nmd.0000202494.75723.83 [DOI] [PubMed] [Google Scholar]
  • 68.Johansen JD, Varvin S. I tell my mother that… sometimes he didn’t love us–Young adults’ experiences of childhood in refugee families: A qualitative approach. Childhood. 2019; 26: 221–235. 10.1177/0907568219828804 [DOI] [Google Scholar]
  • 69.Johansen JD, Varvin S. Negotiating identity at the intersection of family legacy and present time life conditions: A qualitative exploration of central issues connected to identity and belonging in the lives of children of refugees. J Adolescence. 2020; 80: 1–9. 10.1016/j.adolescence.2020.01.016 [DOI] [PubMed] [Google Scholar]
  • 70.Bager L, Hansen KS, Andersen CJ, Wang SJS. Does multidisciplinary rehabilitation of tortured refugees represent ‘value-for-money’? A follow-up of a Danish case-study. BMC Health Serv Res. 2018; 18: 1–14. 10.1186/s12913-017-2770-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Leuzinger-Bohleber M, Rickmeyer C, Tahiri M, Hettich N. Special Communication. What can psychoanalysis contribute to the current refugee crisis? Preliminary reports from Step-By-Step: A psychoanalytic pilot project for supporting refugees in a “first reception camp” and crisis interventions with traumatized refugees. Int J Psychoanal. 2016; 97: 1077–93. 10.1111/1745-8315.12542 [DOI] [PubMed] [Google Scholar]
  • 72.Song SJ, Subica A, Kaplan C, Tol W, de Jong J. Predicting the Mental Health and Functioning of Torture Survivors. J Nerv Ment Dis. 2018; 206: 33–39. 10.1097/NMD.0000000000000678 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Melita J Giummarra

23 Jul 2020

PONE-D-20-12948

The 10-Year Course of Mental Health, Quality of Life, and Daily Life Functioning in Traumatized Refugees from Treatment Start

PLOS ONE

Dear Dr. Opaas,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The reviewer has identified several important points that you must address in order to meet the publishing criteria of PLOS ONE, and to improve the clarity and replicability of your research.

Please submit your revised manuscript by Sep 06 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Melita J. Giummarra

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (a) whether consent was informed and (b) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If the need for consent was waived by the ethics committee, please include this information.

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for an interesting study regarding the course of mental health, quality of life, and daily functioning inf traumatized refugees. This manuscript is very long and repetitive (e.g. multiple times you discuss the study details) such that the reader tends to get lost in the detail. It would be beneficial to refine the introduction to be more concise and focussed on the main aim of this study and reduce the repetition in the Methods. In addition, there are Results included in Methods such that it is unclear to the reader when your results section commenced.

Below are some specific comments:

1. Introduction: I found the introduction, whilst extremely interesting, it was too long and needs to have a clearer path towards the overall aim of this paper. For example, lines 86 to 151 seems to be discussing therapies, but your participants seemed to be provided with a wide variety of treatments from a variety of specialists (e.g. lines 277 to 286). It is unclear that your models measured the nature of the treatment?

2. Sample size: Please perform a power analysis for your mixed methods models (Note: there are a number of R packages that can perform these for you)

3. Participants: Please report on the proportion from Asia, Europe and Africa as these continents do differ and the reader should understand the mix of your participants

4. Procedures: It is unclear as to the distribution of timing of termination of therapy as in line 265 you state “…. Termination of therapy, whenever that occurred”.

5. Measures: Please provide citations for your clinical cutoff. Also, please ensure you outline to the reader what high scores of your measures mean. Please clarify if these are self-report measures as you reference the DSV-IV but it does not appear to be SCIDs?

6. Measures: Please provide the relevant research behind your development of the “Daily life function”

7. Missing Data: Please report on the missing data on both the time invariant and time varying variables.

8. Table 2: Please include base at each time point and for each measure. Also, your title indicates this is a 10-year study, but Table 2 only reports up to the first 3 years. Please provide the relevant information.

9. Diagnostic Evaluation: (Lines 339-350) It is very unclear who coded the ICD-10 diagnoses and at what time period(s) these diagnoses occurred? This is the first time ICD-10 has been mentioned and requires more clarification as these do not appear to be clinical diagnoses so it is unclear as to why they are referred to? ICD-10 is predominantly used for billing purposes and within hospitals for general diagnoses and procedure reporting. Also, please define “ICD-10” to the reader.

10. Statistical Procedures: You indicate you modelled time “as continuous from T1” (Line 363) but this assumes equal time periods but you have T1 baseline, 1 year, then 3 years, then it is unclear the other time periods? LME assumes a linear relationship for equal increments and this does not appear to be the case for your data. Did you perform a sensitivity analysis with time as a categorical variable with T1 as base reference? If not, please do so.

11. Statistical Procedures: Please include the ICC.

12. Statistical Procedures: In your LME models, did you control for potential time invariant confounders such as continent? What interactions with time did you test?

13. Results: Please provide sample sizes for all your results as it appears much of your results are based on small sample sizes. For example, Changes in Daily Life Functioning have n<10.

14. Results: Your graphs extend to 6 years, but your descriptives are up to T3 and the title of your manuscript indicates up to 10 years. Please ensure your time points are consistent for the reader.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 31;15(12):e0244730. doi: 10.1371/journal.pone.0244730.r002

Author response to Decision Letter 0


10 Sep 2020

PONE-D-20-12948 PLOS ONE

The 10-Year Course of Mental Health, Quality of Life, and Exile Life Functioning in Traumatized Refugees from Treatment Start

Response to reviewers

(Our replies/comments in italics)

1. Response to academic editor

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have rechecked PLOS ONE’s style requirements and made the ensuing corrections. I hope the style is now correct.

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (a) whether consent was informed and (b) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If the need for consent was waived by the ethics committee, please include this information.

Under Design in the Methods section, we added the last sentences (here in italics) to the following passage: “The study was approved by the Norwegian South-East Regional Committee for Medical and Health Research Ethics [61] and therapy was conducted according to the Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [62]. Participants’ written, informed consent was required to take part in the study. The first consent was limited to three years. After three years, the participants were asked if they wanted to continue taking part in the study, and those who accepted, gave a new, non-time-limited informed and written consent.” Furthermore, under Procedures in the Methods section, the following is specified (with new parts in italic): “Participants were carefully informed, in writing and verbally, about the purpose of the study, about confidentiality, that participation in the study was voluntary, that rejecting was of no consequence for their treatment, and that, if they signed up for the study, they could withdraw at any time. Seventy-two patients were asked to participate in the study, and 54 accepted and gave their written consent (75% inclusion).”

3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

We have uploaded the minimal anonymized data set necessary to replicate our study findings as Supporting Information files.

2. Response to reviewer

Thank you very much for your time reviewing our manuscript and for helpful comments.

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Answers are given below to the specific comments from the reviewer.

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Answers are given below to the specific comments from the reviewer.

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy <http://www.plosone.org/static/policies.action#sharing> requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

We have now uploaded the data underlying our findings as Supporting Information files.

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Thanks for this positive assessment.

Reviewer’s comments (normal font) and our responses (in italics)

1. Introduction. : I found the introduction, whilst extremely interesting, it was too long and needs to have a clearer path towards the overall aim of this paper. For example, lines 86 to 151 seems to be discussing therapies, but your participants seemed to be provided with a wide variety of treatments from a variety of specialists (e.g. lines 277 to 286). It is unclear that your models measured the nature of the treatment?

We have tried to shorten and focus the introduction in a better way, as recommended. It is true that our models did not measure the nature of the treatment. We have therefore omitted the discussion of therapy methods in the introduction. We have also omitted the part on whether treatment results in this patient group represents “value for money”, and made some additional adjustments to the introduction, hopefully representing a clearer path towards the aim of the paper. However, we have kept passages that more generally refer to results of therapy for this patient group. We have also kept passages leading up to the importance of longitudinal studies, and passages commenting on how or whether length of treatment is related to treatment outcome. Part of our participants received very long treatments, but they may not have progressed correspondingly.

2. Sample size: Please perform a power analysis for your mixed methods models (Note: there are a number of R packages that can perform these for you).

In 2006 we consulted two statisticians about sample size in our study. They said a sample size of 100 would be better, but they gave the opinion that with reasonable effect sizes of expected changes, and repeated measurements, we could still do meaningful analyses with an N of about 50. At that time, we did not have resources to continue including more participants to the study. Aims of the study were multiple, and part of the aims were explorative, since in-depth, longitudinal and multi-method studies of this patient group was largely non-existing at the time – and is still scarce.

A formal power analyses was thus not performed at the beginning of our study. A power analysis after data collection is not recommended. We refer to the following from Lydersen (2019): “After the study, it is generally recommended to report an estimate and a 95 % confidence interval for the effect, as well as a p-value. Sometimes, a journal or a reviewer requests a calculation of the ‘observed power’ in addition (2). This means a statistical power calculation based on the observed effect, as if it were a future study, and reporting it as if it gives additional information about the study already performed. This is not only fundamentally flawed, but it gives no information in addition to the reported p-value” (p. 1). Ref.: Stian Lydersen (2019). Statistical power: Before, but not after! Tidsskrift for den norske legeforening (Journal of the Norwegian Medical Association). (https://tidsskriftet.no/en/2019/01/medisin-og-tall/statistical-power-not-after). This article includes further references with the same conclusion.

3. Participants: Please report on the proportion from Asia, Europe and Africa as these continents do differ and the reader should understand the mix of your participants.

The distribution of backgrounds has now been added: “The participants, 35 men and 19 women, came from 15 different countries in Asia, Europe, and Africa. Of these, 57.4% (n = 31) came from countries in the Middle East, 16.7% (n = 9) came from other Asian countries, 16.7% (n = 9) came from countries in the Balkans, and 9.3% (n = 5) came from various African countries.

4. Procedures: It is unclear as to the distribution of timing of termination of therapy as in line 265 you state “…. Termination of therapy, whenever that occurred”.

In the process of avoiding repetitions in the manuscript, this phrase disappeared. The meaning was, however, “termination of therapy, which occurred after individually varying lengths of therapy”.

5. Measures: Please provide citations for your clinical cutoff. Also, please ensure you outline to the reader what high scores of your measures mean.

In the instruments section, references for the clinical cutoff is now provided for HTQ, part IV and for HSCL-25. The meaning of high scores should also now be clear in the description of the instruments.

Please clarify if these are self-report measures as you reference the DSV-IV but it does not appear to be SCIDs?

The symptom measures are all based on the instruments used in the study, which are described in the Instruments section. The interviewers (a specialist in clinical psychology, and a specialist in psychiatry/psychoanalyst) generally read the questions/items to the participants, asked follow-up questions if the participant’s answer was unclear, and noted their responses. In the Instruments section, we have added the following: “According to Mollica et al. [58], the HSCL- 25 and the HTQ were not designed as a self-report, but should always be administered to traumatized refugees by health care workers, in an atmosphere of empathy.”

In the Procedures section of the current manuscript, we have added the words marked in italic: “As recommended by Mollica et al. [58], the checklists and questionnaires were completed in the presence of the researchers, who offered assistance and explanations when needed, and who listened and responded in an atmosphere of empathy. Most of the participants preferred that the researchers read the questionnaire and checklist items to them and noted their responses.”

In the first publication from the study in 2013 [55]), the procedure was outlined in more detail: “All questionnaires were administered personally by the researchers, question by question, and translated, when needed, orally, on the spot. Associations to the questions and exemplifications of the answers were allowed. We asked several follow-up questions before placing a check mark noting the intensity of the problem. These procedures were time consuming, but gave us indications of how the questions were understood and added important information elaborating the fixed choices of answers in the questionnaires. Mollica et al. (2004) recommended that the HSCL-25 and the HTQ always be administered to traumatized refugees by health care workers, in an atmosphere of listening with empathy. They stated that neither instrument was designed as a self-report.”

Reference to DSM-IV:

The HTQ instrument is described with reference to DSM-IV in its manual. We have added the full name of the DSM-IV. In our manuscript, under Instruments, we describe the HTQ the following way: “The Harvard Trauma Questionnaire, Symptoms of PTSD (HTQ, Part IV, Questions 1-16) [58], is a symptom checklist consisting of 16 items derived from the criteria for PTSD in the Diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) [60],…”. So as not to cause any misunderstanding elsewhere in the manuscript, we removed the words “DSM-IV-based” from other references to the results of the symptom checklists.

6. Measures: Please provide the relevant research behind your development of the “Daily life function”.

In the Introduction we have added a passage about the interdependence between mastering the language of the host country, completing education or holding employment and mental health, wellbeing, and of functioning well in exile. Thanks for making us aware of this omission in the introduction. Throughout the text we have changed the expression “daily life function” to “exile life functioning”/” functioning in exile”. We found this to be more precise.

7. Missing data: Please report on the missing data on both the time invariant and time varying variables.

Participants’ needs and (lack of) endurance had priority before our needs and plans as researchers. At some follow-ups, participants willingly talked with us on the qualitative parts of the follow-up, but refrained from, or had to leave before responding to one or more of the questionnaires. However, as questionnaires and symptom checklists were conducted in interview form, there were not many missing items within the questionnaires, once they were responded to at all. We conducted around 500 interviews during this longitudinal study, both the number of interviews and their timings varied considerably between participants. It would be too much detail if we were to outline each time we had a follow-up with any of the participants when one or more of the questionnaires were not completed.

We have described in general terms in the Procedures section that participants were recruited consecutively over three years, and that they were interviewed at different dates and intervals. In the beginning of the Results section, under Descriptives, we have described how many times each questionnaire was in fact completed, and over what period of time.

The way the data was arranged for this analysis, allowed us to see how many times each participant completed each questionnaire, the date for each completion, and across how many years each respondent responded to the questionnaires.

The following is now described in the Statistical procedures section,: “To examine changes in mental health symptoms and QOL, including all measures obtained at different times and intervals for the 54 participants over the 10 years of study, we used linear mixed effects (lme). lme is a statistical method suited to analyse repeated measurements in longitudinal studies, even when number of observations and the observation times differ among subjects [67,68]. Time was modelled as continuous from T1. All measures over the entire research period were utilized to estimate the progress. Missing data were left missing. 80 % of the items comprising each variable had to be completed if the variable was to be computed. ”

8. Table 2: Please include base at each time point and for each measure.

We do not fully understand this comment. Data was collected at different times and intervals. Please see our comments on point 7.

Also, your title indicates this is a 10-year study, but Table 2 only reports up to the first 3 years. Please provide the relevant information.

To avoid confusion of what belongs to the lme, which is the main analysis of the current study, the original Table 2 is removed and merged with Table 1 (Table 1. Demographics, mental health symptoms, quality of life, and indicators of functioning in exile upon entering therapy and the study). It now only shows results from intake – baseline. We have omitted data from T2 and T3, because they are not a result of the lme, but were formerly modelled for an earlier publication, before the data collection was completed. Table 1 is shown in the Methods section. Data from intake/baseline is included in, but not a result of the present study.

Furthermore, to ease consistency, we have now changed the modelled trajectories in Figures 1 and 2 to show the whole 10-year period, and made sure the results are described and illustrated for 10 years throughout the study.

The data for the lme were organized consecutively, including results from each time each questionnaire was completed by each participant, and at what date. In the lme, for each individual, time for each follow-up questionnaire response was calculated from the study intake date to the date of each follow-up.

9. Diagnostic Evaluation: (Lines 339-350) It is very unclear who coded the ICD-10 diagnoses and at what time period(s) these diagnoses occurred? This is the first time ICD-10 has been mentioned and requires more clarification as these do not appear to be clinical diagnoses so it is unclear as to why they are referred to? ICD-10 is predominantly used for billing purposes and within hospitals for general diagnoses and procedure reporting. Also, please define “ICD-10” to the reader.

All Norwegian mental health clinics, part of the Norwegian specialized health care system, use ICD-10 (The International Statistical Classification of Diseases and Related Health Problems, 10th Revision, WHO, 1994) as their formal diagnostic system. Maybe reporting of the diagnostic evaluation from the clinics only serves to confuse. To make the manuscript more readily understandable and straight forward, we have omitted information about what diagnoses the participants were given in the treatment unit.

10. Statistical procedures: You indicate you modelled time “as continuous from T1” (Line 363), but this assumes equal time periods but you have T1 baseline, 1 year, then 3 years, then it is unclear the other time periods.

In the Results section, under Descriptives, and in the Methods section, the variability in number of follow-ups and variability of intervals between follow-ups among the participants is described. Please also see our response to point 8.

LME assumes a linear relationship for equal increments and this does not appear to be the case for your data. Did you perform a sensitivity analysis with time as a categorical variable with T1 as base reference? If not, please do so.

Mixed effects models have the advantage of not assuming equal increments, and the measurement times may vary between participants. The lme modelled linear trajectories of the scores of the symptom clusters and quality of life dimensions. All model assumptions are approximations, but we have now checked non-linearity without finding indications of systematically non-linear trajectories. As illustrations, plots including smooth curves for PTSD, anxiety, depression and the quality of life dimensions are included as Supplemental files. As we have described, and as can be seen on the smooth curves, the results are more uncertain for the last few years, as these included responses from only a few participants, potentially a selected part of the sample.

11. Statistical procedures: Please include the ICC.

Our mixed effects models include random variation between persons both for the intercept and the slope, therefore an intraclass correlation is not available based on these models.

12. Statistical Procedures: In your LME models, did you control for potential time invariant confounders such as continent? What interactions with time did you test?

There are widely different cultures represented in each continent, so in our view, it will not make sense to control for continents. Moreover, the distribution of participants is not equally dispersed among the continents. This study is based on eligible participants, without regard to national origins, among patients being referred to, and accepted for treatment, as naturally occurring in the Norwegian mental health services that we collaborated with at the time of inclusion (2006-2009). We did not test any possible confounders at this point.

13. Results: Please provide sample sizes for all your results as it appears much of your results are based on small sample sizes. For example, Changes in Daily Life Functioning have n<10.

We see that the way this was formerly outlined could be unclear. In Table 1, all N’s are now within the table. Changes in Daily Life Functioning, now termed Exile life functioning, occurred only in 10 or less (n) from intake to the study until our last meeting with each participant, but the investigated N included all of the 54; the ones who changed as well as the rest of the sample who did not change status from intake to our last meeting with them, whether they at intake already held a job and could communicate in Norwegian or not. In the Results section, Changes in Exile life functioning, we have tried to state more clearly the bases for these calculations. Sample sizes throughout the study for the data included in the lme cannot be given for reasons explained under point 7, but the number of completed questionnaires are described under Descriptives in the Results section.

14. Results: Your graphs extend to 6 years, but your descriptives are up to T3 and the title of your manuscript indicates up to 10 years. Please ensure your time points are consistent for the reader.

Please see our response to point 8. We hope the manuscript will now appear consistent throughout.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

James Curtis West

23 Nov 2020

PONE-D-20-12948R1

The 10-year course of mental health, quality of life, and exile life functioning in traumatized refugees from treatment start

PLOS ONE

Dear Dr. Opaas,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Thank you for your thorough attention to reviewer comments on the original manuscript. Please attend to the additional comments of the statistical review.

Please submit your revised manuscript by Jan 07 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

James Curtis West, M.D.

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for answering my review questions, clarifying your research methodology and arguing your stance.

Reviewer #2: A 10-year longitudinal study was conducted to study the changes in symptoms of posttraumatic stress, anxiety and depression in refugee participants receiving psychotherapy. Linear mixed effect models were used to determine changes in quality of life measures. Symptoms, quality of life, and exile life functioning improved over the course of the study.

Minor revisions:

1- There are procedures/macros available outside of the mixed effects models which can be used to calculate intraclass correlation coefficients.

2- Indicate the covariance structure used in the linear mixed model and the criteria for selecting it.

3- Within the manuscript, state and justify the study’s target sample size with a pre-study statistical power calculation for the mixed model.

4- When data is missing, indicate the analyzed sample size.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 31;15(12):e0244730. doi: 10.1371/journal.pone.0244730.r004

Author response to Decision Letter 1


25 Nov 2020

Thank you again for reviewing our manuscript, our comments to the previous review, and for your new comments.

6. Review Comments to the Author

Reviewer #1: Thank you for answering my review questions, clarifying your research methodology and arguing your stance.

Reviewer #2: A 10-year longitudinal study was conducted to study the changes in symptoms of posttraumatic stress, anxiety and depression in refugee participants receiving psychotherapy. Linear mixed effect models were used to determine changes in quality of life measures. Symptoms, quality of life, and exile life functioning improved over the course of the study.

Minor revisions:

1- There are procedures/macros available outside of the mixed effects models that can be used to calculate intraclass correlation coefficients.

Response: The question of whether to report an intraclass correlation based on our mixed effects models is not a question of lack of software. All computations involving random effects in our mixed effects models may be done within the estimated models, with no need for external software.

As commented in our previous reply, it is not clear what could be the meaning of an intraclass correlation coefficient, in a mixed effects model with between person random variation both in the intercept and the slope. An intraclass correlation is defined in terms of standard deviations for random effects within and between persons, in a mixed effects model with only one random effect within and one random effect between persons. In our models, there is only one random effects within persons, but two random effects between persons.

2- Indicate the covariance structure used in the linear mixed model and the criteria for selecting it.

Response: We have included a random effect for within person variation and random effects for variation in intercept and slope between persons. We have not included a further covariance structure for the error terms within persons, and we have not stated that such a structure is part of the model. The reason is that the time points, and the number of time points, varies considerably between subjects. This may be a limitation, but we do not see a possibility for hypothesizing a specific covariance structure for such a case.

3- Within the manuscript, state and justify the study’s target sample size with a pre-study statistical power calculation for the mixed model.

Response: As commented in our replies in the previous round, there was not performed a formal sample size calculation when the study was initiated back in 2006. This is a limitation, but there is no way this could be rectified now since post hoc sample size calculations are methodologically flawed, as detailed in references given in our previous reply. We have added the lack of a pre-study power calculation to Limitations, page 28, line 599.

4- When data is missing, indicate the analyzed sample size.

Response: Sample sizes and all details of the pretreatment assessment and the assessment of all participants one and three years after inclusion into the study are described in former publications (Opaas and Hartmann, 2013; Opaas and Varvin, 2015; Opaas, Hartman, Wentzel-Larsen, & Varvin, 2016).

Except for these three coordinated assessment points, all other assessment points were random, that is, not coordinated according to the time of inclusion into the study for each individual. Therefore, it is not meaningful to speak of missing data and sample size at each point in time. The statistical method chosen is suited for such data, where time between each measurement and the number of assessments varies among the participants.

In Procedures, page 13, line number 249 to 252, an addition is made to make the nature of the data clearer.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

James Curtis West

16 Dec 2020

The 10-year course of mental health, quality of life, and exile life functioning in traumatized refugees from treatment start

PONE-D-20-12948R2

Dear Dr. Opaas,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

James Curtis West, M.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for your persistence in completing revisions to this manuscript.

Reviewers' comments:

Acceptance letter

James Curtis West

22 Dec 2020

PONE-D-20-12948R2

The 10-year course of mental health, quality of life, and exile life functioning in traumatized refugees from treatment start

Dear Dr. Opaas:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. James Curtis West

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Smooth curves to check for non-linearity.

    (PDF)

    S1 Data. HTQ PTSD datafile.

    (SAV)

    S2 Data. HSCL-25 anx_depr datafile.

    (SAV)

    S3 Data. WHOQOL qol datafile.

    (SAV)

    S4 Data. LanguageWorkStudy datafile.

    (SAV)

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES